Getting to know GH&B

• Global Hospital & Biosimilars (GH&B) makes the products that are the foundation of hospital care – sterile injectables and biosimilars – that reach more than 100 million patients annually, generating $5 billion in revenue for Pfizer. These are not niche products; they are for when patients are at the most vulnerable, essential to access and acute care delivery worldwide.

• GH&B is Pfizer's only truly end-to-end business, spanning from our 12 global manufacturing sites through to commercial in a single integrated organization. It was created to give this portfolio dedicated focus, clearer accountability, and a fit-for-purpose operating model – recognizing that GH&B's portfolio has different economics, customer dynamics, and execution needs than Pfizer's innovative business.

• By bringing Commercial and Supply into one organization, GH&B enables faster decision-making, stronger prioritization, and expanded capabilities for this important portfolio.

• Our ambition: Rebuild a healthy operation positioned to serve patients for generations to come

Use Your Power for Purpose

• The European Cluster Lead holds full P&L accountability for the commercial business acrossNorthern Europe, Central Europe, and the Mediterranea – a diverse set of markets varying in size and maturity, operating across both tender-driven and contract-driven commercial models. 

• Distinguished by a plant-to-patient perspective, the role spans the full commercial value chain, from portfolio and pricing strategy through tender and contracting execution to patient access, across biosimilars and generics (Oncology, Immunology/Inflammation).

• This is a 12-month interim leadership mandate and the perfect opportunity for entrepreneurial leaders: the European Cluster Lead will oversee and shape the European operating model including the SLA relationships during its critical first year, setting strategic direction across in-market and launch assets while balancing standardization with calibration to local market realities.

What You Will Achieve

P&L Leadership & Resource Allocation

• Own the full P&L (USD~$450-600M)across various markets; set strategic direction across markets; manage varying revenue growth trajectories and margin profiles between a mix of direct and SLA-based ownership

• Allocate resources and prioritize portfolio investments across regional markets based on growth potential, competitive intensity, and portfolio mix as well as maturity

• Calibrate investment between larger markets’ scale and growth potential in smaller markets

• Represent Europe in global planning cycles (e.g., strategic reviews)

• Define key outcomes and success metrics for the 12-month interim period

Commercial Excellence & Portfolio Steering

• Set commercial direction forin-market assets across all cluster markets whileidentifying growth opportunities via portfolio expansion

• Leverage the Commercial Performance Teamfor performance tracking, commercial KPIs, and data-driven insights to optimize resource allocation and commercial execution across all markets

• Ensure contract excellence and pricing discipline across negotiation-driven markets

• Drive tendering strategy and execution excellence across tender-driven markets, ensuring competitive positioning and win-rate optimization

• Provide strategic direction to regional Portfolio Management & Marketing Leads, ensuring alignment on portfolio priorities, launch sequencing, and marketing investment

• Leverage commercial performance analytics to drive field force effectiveness and customer engagement standards across Account Management and T&C teams

• Navigate complex and diverse payer systems across the European markets — including SHI, reference pricing, and canton-based frameworks

• Lead CSO/distribution partnerships with full accountability for relationship management, performance oversight, and service delivery outcomes —including SLA governance (scope, KPIs, transition triggers) — and drive the strategic evolution from VMG reliance toward a self-sufficient, fit-for-purpose commercial capability

External Environment & Stakeholder Navigation

• Serve as the face of Pfizer GH&B to local external stakeholders — governments, regulators, payers, KOLs, and industry bodies in conjunction with the innovative medicines group as relevant

• Navigate complex and divergent stakeholder systems across the cluster markets

• Coordinate with global functions (Medical, Regulatory, Supply) and serve as escalation point for platform support

• Collaborate with the broader Pfizer organization to align with the Innovative portfolio and secure resources and functional support (Medical, Finance, Legal, Compliance, GAV)

Enterprise Leadership & Talent Development

• Lead multiple colleagues across all cluster markets, including distributed teams not co-located with you

• Direct oversight of regional Portfolio Management & Marketing Leads;withcommercial performance support

• Operate in a matrix — lead and influence enabling functions without direct reporting lines

• Attract, develop, and retain talent; build leadership pipeline across geographies

• Lay the structural foundation for the future-state operating model — design the organizational blueprint, define leadership roles, and prepare the organization to transition into a fully self-sufficient commercial structure from Year 2 onward

Technology & AI Enablement

• Champion adoption of AI-enabled ways of working and foster a culture of continuous learning and innovation

• Leverage technology, data, and AI-driven insights to inform strategy, accelerate decision making, and improve organizational performance

• Demonstrate strong personal digital literacy and AI fluency, modelling practical use of data, digital tools, and AI-enabled solutions

• Leverage AI-driven dashboards for real-time cluster performance visibility and proactive resource reallocation

• Identify and scale opportunities for automation, simplification, and digital transformation.

• Ensure responsible use of AI through appropriate governance, risk awareness, and human oversight

Key Capabilities

• Leading Through Change: Demonstrated experience leading leaders and teams through complex change, including navigating ambiguity, influencing across stakeholders, and sustaining performance during transformation

• End-to-End Process Thinking: Proven ability to think and operate end-to-end, connecting strategy to execution across functions and anticipating downstream impacts to deliver integrated, enterprise-level solutions

Here Is What You Need (Minimum Requirements)

• Bachelor's degree required; MBA or relevant advanced degree preferred

• 12+ years commercial experience in healthcare/pharma, including P&L management and multi-market leadership

• Significant commercial experience in biosimilars, generics, or established brands required

• Fluency in English required

• Demonstrated ability to lead across diverse regulatory systems and market archetypes, ideally with knowledge of the European access landscape

• Track record of building commercial capabilities in scaling organizations

Bonus points if you have (preferred requirements)

• Master's degree with relevant pharmaceutical industry experience

• Leadership experience in one or more of the respective cluster markets

• Transformation experience, particularly in technology enabled ways of working

• Ability to build and leverage constructive relationships across various divisions

• Experience in leading cross-functional teams

• Strategic thinking and innovative mindset

• Strong negotiation and influencing skills

• German and additional cluster language skills an asset